CN1145030A - 用于治疗疟疾的氯氟菲醇游离碱及组合物 - Google Patents
用于治疗疟疾的氯氟菲醇游离碱及组合物 Download PDFInfo
- Publication number
- CN1145030A CN1145030A CN95192440A CN95192440A CN1145030A CN 1145030 A CN1145030 A CN 1145030A CN 95192440 A CN95192440 A CN 95192440A CN 95192440 A CN95192440 A CN 95192440A CN 1145030 A CN1145030 A CN 1145030A
- Authority
- CN
- China
- Prior art keywords
- preparation
- halofantrine
- free alkali
- solid
- alkali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9406858A GB9406858D0 (en) | 1994-04-07 | 1994-04-07 | New use and formulations |
GB9406858.2 | 1994-04-07 | ||
GB9416404.3 | 1994-08-13 | ||
GB9416404A GB9416404D0 (en) | 1994-08-13 | 1994-08-13 | New use and formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1145030A true CN1145030A (zh) | 1997-03-12 |
Family
ID=26304653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN95192440A Pending CN1145030A (zh) | 1994-04-07 | 1995-04-04 | 用于治疗疟疾的氯氟菲醇游离碱及组合物 |
Country Status (16)
Country | Link |
---|---|
US (1) | US5968987A (hu) |
EP (1) | EP0754045B1 (hu) |
JP (1) | JPH09512794A (hu) |
CN (1) | CN1145030A (hu) |
AT (1) | ATE213937T1 (hu) |
AU (1) | AU685263B2 (hu) |
BR (1) | BR9507437A (hu) |
CA (1) | CA2187185A1 (hu) |
CZ (1) | CZ293696A3 (hu) |
DE (1) | DE69525740T2 (hu) |
ES (1) | ES2170143T3 (hu) |
HU (1) | HUT76051A (hu) |
NO (1) | NO964238L (hu) |
NZ (1) | NZ284068A (hu) |
PL (1) | PL179608B1 (hu) |
WO (1) | WO1995027492A1 (hu) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998029136A1 (en) * | 1996-12-27 | 1998-07-09 | Takeda Chemical Industries, Ltd. | Stabilized tricyclic compound |
US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
IN191696B (hu) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
US6759058B1 (en) * | 2001-04-25 | 2004-07-06 | Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences | Enteric-coated proliposomal formulations for poorly water soluble drugs |
AUPR573001A0 (en) * | 2001-06-15 | 2001-07-12 | Glaxo Wellcome Australia Ltd | Lymphatic drug delivery system |
WO2003041632A2 (en) | 2001-11-14 | 2003-05-22 | Texas Tech University | Eutectic-based self-nanoemulsified drug delivery system |
US20060148776A1 (en) * | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
EP1670325A1 (en) | 2003-09-29 | 2006-06-21 | Soft Gel Technologies, Inc. | SOLUBILIZED CoQ-10 |
US20050220866A1 (en) * | 2004-04-02 | 2005-10-06 | Dr. Reddy's Laboratories Limited | Novel capsule formulations of etoposide for oral use |
US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
SA109300195B1 (ar) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | تركيبة صيدلانية جديدة مضادة للسرطان |
CA2690490C (en) * | 2010-01-19 | 2012-06-26 | Accucaps Industries Limited | Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
US9309136B2 (en) * | 2014-06-12 | 2016-04-12 | Tersus Environmental, Llc | Bioremediation of soil and groundwater |
CN107073127A (zh) * | 2014-06-19 | 2017-08-18 | 索露奥公司 | 亲脂性化合物的固体口服剂型 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4507288A (en) * | 1983-09-16 | 1985-03-26 | Smithkline Beckman Corporation | β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds |
US4818767A (en) * | 1983-11-02 | 1989-04-04 | Smithkline Beckman Corporation | Quinate salts of antimalarial phenanthrenemethanol compounds |
US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
AP9200405A0 (en) * | 1991-07-15 | 1994-01-13 | Smithkline Beecham Ag | Pharmaceutical formulations comprised of micronised halofantrine. |
-
1995
- 1995-04-04 WO PCT/EP1995/001257 patent/WO1995027492A1/en not_active Application Discontinuation
- 1995-04-04 CA CA002187185A patent/CA2187185A1/en not_active Abandoned
- 1995-04-04 CZ CZ962936A patent/CZ293696A3/cs unknown
- 1995-04-04 CN CN95192440A patent/CN1145030A/zh active Pending
- 1995-04-04 HU HU9602740A patent/HUT76051A/hu unknown
- 1995-04-04 EP EP95915852A patent/EP0754045B1/en not_active Expired - Lifetime
- 1995-04-04 AU AU22568/95A patent/AU685263B2/en not_active Ceased
- 1995-04-04 ES ES95915852T patent/ES2170143T3/es not_active Expired - Lifetime
- 1995-04-04 AT AT95915852T patent/ATE213937T1/de not_active IP Right Cessation
- 1995-04-04 JP JP7526060A patent/JPH09512794A/ja active Pending
- 1995-04-04 BR BR9507437A patent/BR9507437A/pt not_active Application Discontinuation
- 1995-04-04 DE DE69525740T patent/DE69525740T2/de not_active Expired - Fee Related
- 1995-04-04 PL PL95316656A patent/PL179608B1/pl unknown
- 1995-04-04 NZ NZ284068A patent/NZ284068A/en unknown
-
1996
- 1996-10-04 NO NO964238A patent/NO964238L/no not_active Application Discontinuation
-
1997
- 1997-10-15 US US08/950,459 patent/US5968987A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69525740D1 (de) | 2002-04-11 |
CZ293696A3 (en) | 1997-01-15 |
NO964238D0 (no) | 1996-10-04 |
PL179608B1 (pl) | 2000-10-31 |
CA2187185A1 (en) | 1995-10-19 |
NZ284068A (en) | 1998-06-26 |
WO1995027492A1 (en) | 1995-10-19 |
HU9602740D0 (en) | 1996-11-28 |
MX9604611A (es) | 1997-11-29 |
PL316656A1 (en) | 1997-02-03 |
HUT76051A (en) | 1997-06-30 |
JPH09512794A (ja) | 1997-12-22 |
NO964238L (no) | 1996-10-04 |
EP0754045A1 (en) | 1997-01-22 |
BR9507437A (pt) | 1997-09-16 |
US5968987A (en) | 1999-10-19 |
AU2256895A (en) | 1995-10-30 |
DE69525740T2 (de) | 2002-10-24 |
EP0754045B1 (en) | 2002-03-06 |
ES2170143T3 (es) | 2002-08-01 |
ATE213937T1 (de) | 2002-03-15 |
AU685263B2 (en) | 1998-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1145030A (zh) | 用于治疗疟疾的氯氟菲醇游离碱及组合物 | |
TW546152B (en) | A storage-stable self-emulsifying preconcentrate of an anticancer drug such as taxane, pharmaceutical composition thereof and a method of enhancing the oral bioavailability of a taxane | |
JP5753157B2 (ja) | 親水性薬剤の自己マイクロエマルジョン化経口医薬組成物およびその調製方法 | |
CN1246058A (zh) | 包含环孢菌素a的无油药物组合物 | |
CN101926757A (zh) | 一种难溶性药物的液体组合物及其制备方法 | |
CN1250377A (zh) | 用于给予环孢菌素的亲水二元体系 | |
BRPI0008228B1 (pt) | composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes | |
CN102048688B (zh) | 以胆固醇复合物为中间载体的紫杉醇亚微乳 | |
CN101390851B (zh) | 双环醇含表面活性剂的药物组合物及其制备方法和制剂 | |
JP2005513096A (ja) | シクロスポリン、親水性界面活性剤及び親油性界面活性剤を含んで成る医薬組成物 | |
EP1249230B1 (de) | Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen | |
EP1184034A2 (en) | Oral drug composition containing a verapamil derivative as a drug-absorption promotor | |
CN1199642C (zh) | 含环孢菌素的新型药物组合物 | |
CA2697328C (en) | Antifungal composition | |
EP1151755B1 (en) | Pharmaceutical compositions comprising cyclosporin as active ingredient | |
JP2942556B2 (ja) | シクロスポリンを含有する新規組成物 | |
CN102058577B (zh) | 一种以双环醇为活性成分的药物组合物及其制剂 | |
US20060233842A1 (en) | Microemulsion composition for oral administration of biphenyldimethyldicarboxylate | |
CN102319302A (zh) | 赤芍总苷自微乳化软胶囊及其制备方法 | |
WO2000009085A2 (en) | Oral formulation containing cyclosporin | |
CN1925856A (zh) | 用于口服吡唑-3-甲酰胺衍生物的药物组合物 | |
CN101264112A (zh) | 川芎油微乳及其制备方法 | |
KR20140132125A (ko) | 포에누모사이드 포함 자가유화 약물전달시스템 조성물 및 이의 제조방법 | |
CN114796511A (zh) | 一种混合型增溶剂及其制备方法 | |
KR20070018003A (ko) | 특정 물질 p 길항제를 포함하는 마이크로에멀젼 제제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |